Reckitt Benckiser Group plc (RKT) has announced the successful launch and pricing of EUR 650 million Floating Rate Notes due November 2028, issued under its GBP 10 billion Euro Medium Term Note Programme. The notes, priced on 2 November 2026 and expected to be issued on 9 November 2026, carry a floating rate of 3-month EURIBOR plus 0.55 per cent. The issuance was made by subsidiary Reckitt Benckiser Treasury Services plc and is guaranteed by Reckitt Benckiser Group plc, with final terms published on 5 November 2026.

Key Points

  • Reckitt Benckiser Group plc (RKT), trading as Reckitt, is a FTSE-listed global consumer health and hygiene company
  • EUR 650 million Floating Rate Notes priced on 2 November 2026 and expected to settle on 9 November 2026
  • Notes carry a floating rate of 3-month EURIBOR + 0.55%, maturing 9 November 2028, under the GBP 10 billion EMTN Programme
  • Investors may watch how this euro-denominated debt issuance fits within Reckitt's broader treasury and balance sheet strategy

EUR 650 Million Notes Priced at EURIBOR Plus 0.55% With Two-Year Maturity

Reckitt Benckiser Treasury Services plc, the issuing entity within the Reckitt group, launched and priced the EUR 650 million Floating Rate Notes on 2 November 2026, with settlement and issuance expected on 9 November 2026. The notes carry a coupon of 3-month EURIBOR plus 0.55 per cent and mature on 9 November 2028, giving them an approximate two-year tenor. The notes are issued under the group's GBP 10 billion Euro Medium Term Note Programme and are guaranteed by Reckitt Benckiser Group plc, the ultimate parent company and listed entity on the London Stock Exchange.

GBP 10 Billion EMTN Programme Provides Framework for Reckitt's Capital Markets Activity

The Euro Medium Term Note Programme, with a total capacity of GBP 10 billion, forms the structural basis through which Reckitt accesses wholesale debt capital markets. Final terms for this issuance, dated 5 November 2026, have been submitted to the National Storage Mechanism and are available via the Financial Conduct Authority's data portal. The final terms are to be read alongside the base prospectus dated 30 October 2026. Reckitt operates in more than 80 countries, employs around 36,000 people, and sells approximately 30 million products daily across categories including Germ Protection, Household Care, Intimate Wellness, and Self Care.

Floating Rate Structure Exposes Reckitt to EURIBOR Movements Over the Notes' Life

Because the notes carry a floating rather than fixed rate, the cost of this borrowing for Reckitt will move in line with 3-month EURIBOR over the two-year term. This structure introduces interest rate sensitivity compared with fixed-rate debt, meaning changes in European interbank rates between issuance and the November 2028 maturity date could affect the group's overall financing costs. Investors monitoring Reckitt's capital allocation and debt management may consider how this instrument interacts with broader euro-denominated liabilities across the group's international operations.

Reckitt's Consumer Health Portfolio Anchors Credit Profile Behind the Guaranteed Issuance

Founded in the United Kingdom in 1840, Reckitt's portfolio of globally recognised brands — including Dettol, Durex, Nurofen, Gaviscon, Finish, Mucinex, and Strepsils — underpins the credit profile supporting this guaranteed debt issuance. The company's self-described mission is to deliver better health in more hands across consumer health and hygiene markets. As guarantor of the notes, Reckitt Benckiser Group plc's operational scale and brand strength in over 80 countries provide the backing for Reckitt Benckiser Treasury Services plc's obligations to noteholders through to the 2028 maturity date.